SCHEMBL7474865

SCHEMBL7474865

CCCCCNc1nc(OC)c(-c2ccc(OC(F)F)cc2OC)nc1CC

nearest known ligand 0.57

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 20/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6203614 0.89 CRHR1 (0.70) CRHR1
SCHEMBL7480024 0.87 CRHR1 (0.57) CRHR1
SCHEMBL7472049 0.85 CRHR1 (0.56) CRHR1
SCHEMBL5421192 0.83 CRHR1 (0.80) CRHR1
SCHEMBL6201263 0.81 CRHR1 (0.62) CRHR1
SCHEMBL7475228 0.81 CRHR1 (0.62) CRHR1
SCHEMBL7474786 0.80 CRHR1 (0.63) CRHR1
SCHEMBL6201786 0.80 CRHR1 (0.60) CRHR1
SCHEMBL7606978 0.79 CRHR1 (0.59) CRHR1
SCHEMBL7475275 0.79 CRHR1 (0.47) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255740-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2002-11-13 EP claimed
WO-2001060806-A2 SUBSTITUTED ARYLPYRAZINES NEUROGEN CORPORATION (US) 2001-08-23 WO claimed